Rocket Lab's NASA Protest and Iridium Bet Test Investor Patience as Shares Sit 59% Below Peak

Rocket Lab shares drop 22% in 30 days as a NASA Mars contract protest and doubts over the $8 billion Iridium takeover offset record launch cadence.

Rocket Lab has spent the past month proving that operational execution and share-price performance can travel in opposite directions. The Long Beach-based launch company is flying Electron missions at a cadence most rivals can only promise, rolling out new satellite hardware, and sitting on a record order book. Yet its stock has shed roughly 22% over 30 days and trades at EUR 54.20 — a full 59% beneath its 52-week high of EUR 133.80.

Two unresolved storylines explain most of that gap: a formal protest against NASA and a multi-billion-dollar acquisition whose appeal is wearing thin.

A Formal Challenge to NASA's Mars Award

On September 11, Rocket Lab filed a protest with the Government Accountability Office over NASA's decision to hand Blue Origin a $700 million contract to build a Mars telecommunications network. The company called NASA's technical review "punitive" and accused the agency of making "incorrect statements."

Congress had already approved the funding in July 2025, with the tender following in May 2026. Under the current plan, Blue Origin is to deliver the orbiter by December 31, 2028, with the system operational at Mars by the end of 2030.

The protest cuts both ways. It signals a company willing to take on a Bezos-backed rival — a mark of confidence in its own portfolio. It also exposes how heavily Rocket Lab's equity story now leans on winning exactly this kind of flagship contract. Should the challenge fail, the market may read it as confirmation that Rocket Lab still trails the sector's giants in deep-space work. Investors have already voted: the stock dropped more than 3% in Monday premarket trading to $60.90, with analysts pointing squarely at the NASA dispute.

Iridium: Enthusiasm Wears Thin

Weighing on sentiment in parallel is the planned $8 billion takeover of Iridium. Shareholders vote on September 24 on the offer of $54 per share, payable half in cash and half in Rocket Lab stock.

The market's nerves around the deal were on display in late August, when a letter from SpaceX to the FCC knocked more than 5% off the share price — a sign of how sensitive investors are to regulatory noise surrounding the transaction. Reports suggest appetite for the deal remains muted, while Iridium itself contends with profit-taking and concerns over debt load and integration risk.

A pattern emerges: Rocket Lab is expanding on multiple fronts at once — strategically through Iridium, operationally through added launch capacity. The company recently unveiled "GHOST," a mobile launch platform designed to fire Electron and HASTE rockets from virtually anywhere, with a first site in Kodiak, Alaska. CEO Peter Beck has positioned the system explicitly for missile defense and national security work. It is an ambitious display of technical breadth, but each of these bets consumes capital and management attention while one core question stays open: can Rocket Lab defend large NASA contracts against Blue Origin and SpaceX over the long run?

The Launch Business Keeps Delivering

Against that backdrop, the core franchise is running hot. On August 10, Rocket Lab reported second-quarter 2026 revenue of $234.07 million with an adjusted loss per share of $0.08. Management guided third-quarter revenue to $250–265 million at a GAAP gross margin of 29–31%, and pointed to a record backlog — evidence that demand for launch vehicles and satellite components is not letting up even as quarterly results remain loss-making.

The next milestone for the larger Neutron rocket — delivery to the launch pad — is slated for the fourth quarter of 2026. No firm date has been set for the maiden flight, and that waiting game is precisely what unsettles investors. Neutron is the vehicle meant to transform Rocket Lab from a small-satellite specialist into a serious contender for heavier payloads.

Meanwhile, the smaller Electron keeps flying. Friday's mission — the 16th Electron launch of 2026 and the 95th overall — carried a satellite for an unnamed Earth-observation customer under the name "Happily Ever Faster." The company has said another Electron flight will follow before the month is out. Days earlier, on September 2, the 94th mission, "Owl Around the World," placed a StriX satellite for Japanese partner Synspective into low Earth orbit. Averaging more than one mission a month is no small feat for a rocket company — it shows Rocket Lab delivering what many competitors only announce.

New Revenue Streams Beyond the Rocket

Rocket Lab is also broadening its space-components portfolio. On September 9, it introduced IMM Apex, a new germanium-free solar cell for satellite and space applications. Media reports noted the announcement lifted the shares before the opening bell — a hint that the market pays attention when Rocket Lab opens new revenue channels beyond launch.

Insider activity added to the chatter. CFO Adam C. Spice exercised employee options on 140,157 shares at $1.09 on September 4 and sold the stock the same day at weighted average prices of $62.26 and $62.97. Such exercises are routine for U.S. executives and do not automatically read as a signal in either direction. On the other side of the ledger, ARK Investment Management added to its position, buying several hundred thousand Rocket Lab shares in early September.

What the Charts Say

The technical picture reinforces the cautious mood. The Relative Strength Index sits at 37.2, with the stock trading 12% below its 50-day moving average and 23% below its 200-day line. This is no crash-style collapse, but a clear sign that investors are stripping growth premiums out of the price that seemed a given in the spring. On Friday, the shares gained 2.1% to close at EUR 54.50, yet the year-to-date loss stands at 11%.

Rocket Lab remains a structurally interesting name in a rising space sector, but the pile-up of open questions — the NASA protest, Iridium uncertainty, regulatory headwinds from SpaceX — argues against a swift rebound. A clearer picture may only arrive once the GAO rules or the September 24 Iridium vote delivers an unambiguous signal. Until then, skepticism outweighs euphoria.